methylprednisolone has been researched along with Fibrocartilaginous Dysplasia of Bone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Funanage, VL; Hobson, GM; Montgomery, BE; Moses, PA; Smith-Kirwin, SM; Stanton, RP | 1 |
1 other study(ies) available for methylprednisolone and Fibrocartilaginous Dysplasia of Bone
Article | Year |
---|---|
Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia.
Topics: Adolescent; Adult; Bone Marrow Cells; Calcification, Physiologic; Cells, Cultured; Child; Dexamethasone; DNA Mutational Analysis; Female; Fibrous Dysplasia of Bone; Glucocorticoids; GTP-Binding Protein alpha Subunits, Gs; Humans; Interleukin-6; Male; Methylprednisolone; Osteoblasts; Point Mutation; Polymerase Chain Reaction; Stromal Cells | 1999 |